Informations:
Erreur:
ID
31905
Description
A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.; ODM derived from: https://clinicaltrials.gov/show/NCT00996203
Lien
https://clinicaltrials.gov/show/NCT00996203
Mots-clés
Versions (1)
- 08/10/2018 08/10/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
8 octobre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Rheumatoid Arthritis NCT00996203
Eligibility Rheumatoid Arthritis NCT00996203
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00996203
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Adult | Age
Item
adult patients, >/= 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid arthritis moderate Duration | Rheumatoid Arthritis Severe Duration
Item
moderate to severe active rheumatoid arthritis of >/=6 months duration
boolean
C2368567 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Non-Biologic DMARDs Response Inadequate
Item
inadequate clinical response to current non-biologic dmards
boolean
C4054347 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
DMARDs Dose Stable
Item
current dmards must be at stable dose for 8 weeks prior to study entry
boolean
C0242708 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Adrenal Cortex Hormones Oral
Item
oral corticosteroids (</=10mg/day prednisone or equivalent) and nsaids must be at stable dose for >/=4 weeks prior to screening
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,2])
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis
Item
rheumatic autoimmune disease other than ra
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
history of or current inflammatory joint disease other than ra
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Biologic DMARD
Item
previous treatment with any biologic dmard
boolean
C4055380 (UMLS CUI [1])
Rheumatoid Arthritis Functional Status Class
Item
functional class iv as defined by the acr classification
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Intraarticular injection of corticosteroids | Adrenal Cortex Hormones Parenteral
Item
intra-articular or parenteral corticosteroids within 6 weeks prior to screening
boolean
C2064783 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
C0001617 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])